Close

More on ENDP

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (4.0 Score)
- Holders
- Event Driven Deals
- FDA Archive

Financials

Income Statement
Balance Sheet
Cash Flow Statement

Upcoming Events

- Spin-Off (9/30/15 *Est)
- M&A (12/31/15 *Est)
- M&A (12/31/20 *Est)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

ENDP Balance Sheet

Click line-items for a historical chart and %
CURRENT ASSETS:
Cash and cash equivalents 526.6M
Marketable securities
Accounts receivable, net 725.83M
Inventories, net 374.44M
Prepaid expenses and other current assets 39.4M
Income taxes receivable 0
Deferred income taxes 257.99M
Total current assets 2.85B
Equity securities, Carrying Amount 2.98M
PROPERTY, PLANT AND EQUIPMENT, NET 372.08M
GOODWILL 1.37B
OTHER INTANGIBLES, NET 1.87B
OTHER ASSETS 96.54M
TOTAL ASSETS 6.57B
CURRENT LIABILITIES:
Accounts payable 263.24M
Accrued expenses 979.96M
Current portion of long-term debt, net 414.93M
Acquisition-related contingent consideration
Total current liabilities 1.7B
DEFERRED INCOME TAXES 310.76M
ACQUISITION-RELATED CONTINGENT CONSIDERATION
LONG-TERM DEBT, LESS CURRENT PORTION, NET 3.32B
OTHER LIABILITIES 654.49M
COMMITMENTS AND CONTINGENCIES (NOTE 12) 0
STOCKHOLDERS' EQUITY:
Common Stock, $0.01 par value; 350,000,000 shares authorized; 137,935,436 and 136,309,917 shares issued; 116,757,314 and 116,057,895 shares outstanding at June 30, 2011 and December 31, 2010, respectively 1.44M
Additional paid-in capital 1.17B
Retained earnings 126.23M
Accumulated other comprehensive loss -4.92M
Treasury stock, 21,178,122 and 20,252,022 shares at June 30, 2011 and December 31, 2010, respectively -763.12M
Total Endo Pharmaceuticals Holdings Inc. stockholders' equity 526.02M
Noncontrolling interests 59.2M
Total stockholders' equity 585.22M
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY 6.57B